Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Qiang Wang, Shixin Xiu, Liuqing Yang, Jinxin Huang, Tingting Cui, Naiyang Shi, Xuwen Wang, Yuan Shen, Enpin Chen, Bing Lu, Hui Jin & Leesa Lin. (2021) Economic evaluation of varicella vaccination strategies in Jiangsu province, China: a decision-tree Markov model. Human Vaccines & Immunotherapeutics 17:11, pages 4194-4202.
Read now
Read now
Jonathan Graham, Lara J. Wolfson, Jeffrey Kyle, Carlos Perez Bolde-Villarreal, Diana B Guarneros-DeRegil, Homero Monsanto, Matthew Pillsbury, Sandra Talbird & Vincent J. Daniels. (2020) Budget impact analysis of multiple varicella vaccination strategies: a Mexico perspective. Human Vaccines & Immunotherapeutics 16:4, pages 886-894.
Read now
Read now
Mark H Rozenbaum, Elisabetta De Cao, Tjalke A Westra & Maarten J Postma. (2012) Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around…. Expert Review of Vaccines 11:12, pages 1415-1428.
Read now
Read now
Articles from other publishers (42)
Robert Anderson, Sungwook Kim, Nia Roberts & Stavros Petrou. (2023) Systematic review of economic evaluations of varicella vaccination programmes. PLOS ONE 18:3, pages e0282327.
Crossref
Crossref
Marc H A Jansen, Christien Rondaan, Geertje E Legger, Kirsten Minden, Yosef Uziel, Natasa Toplak, Despoina Maritsi, Lotte van den Berg, Guy A M Berbers, Patricia Bruijning, Yona Egert, Christophe Normand, Marc Bijl, Helen E Foster, Isabelle Koné-Paut, Carine Wouters, Angelo Ravelli, Ori Elkayam, Nicolaas M Wulffraat & Marloes W Heijstek. (2023) EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Annals of the Rheumatic Diseases 82:1, pages 35-47.
Crossref
Crossref
Shixin Xiu, Xuwen Wang, Qiang Wang, Hui Jin & Yuan Shen. (2023) Impact of implementing a free varicella vaccination policy on incidence in Wuxi City, China: an interrupted time series analysis. Epidemiology and Infection 151.
Crossref
Crossref
Elena Bozzola, Silvio Marchesani, Andrea Ficari, Carla Brusco, Giulia Spina, Maria Rosaria Marchili & Stefano Guolo. (2022) Assessing the use of antibiotics in pediatric patients hospitalized for varicella. Italian Journal of Pediatrics 48:1.
Crossref
Crossref
Manjiri Pawaskar, Jaime Fergie, Carolyn Harley, Salome Samant, Phani Veeranki, Oliver Diaz & James H. Conway. (2022) Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States. PLOS ONE 17:6, pages e0269916.
Crossref
Crossref
Matthew Pillsbury, Cristina Carias, Salome Samant, David Greenberg & Manjiri Pawaskar. (2022) Comparison of performance of varicella vaccines via infectious disease modeling. Vaccine 40:29, pages 3954-3962.
Crossref
Crossref
Nidhi Shah & A. Yasmine Kirkorian. 2022. Pediatric Dermatology. Pediatric Dermatology
108
132
.
Manjiri Pawaskar, Estelle Méroc, Salome Samant, Elmira Flem, Goran Bencina, Margarita Riera-Montes & Ulrich Heininger. (2021) Economic burden of varicella in Europe in the absence of universal varicella vaccination. BMC Public Health 21:1.
Crossref
Crossref
Jessica Vandenhaute, Elyonore Tsakeu, Pierre Chevalier, Manjiri Pawaskar, Goran Benčina & Jan Vertriest. (2021) Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis. BMC Infectious Diseases 21:1.
Crossref
Crossref
Cornelis Boersma & Maarten J. Postma. (2021) Health Economics of Vaccines: From Current Practice to Future Perspectives. Value in Health 24:1, pages 1-2.
Crossref
Crossref
Ellen R.S. Rafferty, Wade McDonald, Nathaniel D. Osgood, Alexander Doroshenko & Marwa Farag. (2021) What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model. Value in Health 24:1, pages 50-60.
Crossref
Crossref
Andrew J. Leidner, Neil Murthy, Harrell W. Chesson, Matthew Biggerstaff, Charles Stoecker, Aaron M. Harris, Anna Acosta, Kathleen Dooling & Carolyn B. Bridges. (2019) Cost-effectiveness of adult vaccinations: A systematic review. Vaccine 37:2, pages 226-234.
Crossref
Crossref
Jacek Wysocki, Ilona Malecka, Joanna Stryczynska-Kazubska, Emmanouil Rampakakis, Barbara Kuter & Lara J. Wolfson. (2018) Varicella in Poland: economic burden in children 1–12 years of age in Poland, 2010–2015. BMC Public Health 18:1.
Crossref
Crossref
Mélanie Drolet, Élodie Bénard, Mark Jit, Raymond Hutubessy & Marc Brisson. (2018) Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value in Health 21:10, pages 1250-1258.
Crossref
Crossref
Magali S. Rüfenacht, Ernesto Montaruli, Eléonore Chappuis, Klara M. Posfay-Barbe & Giorgio C. La Scala. (2016) Skin-Sparing Débridement for Necrotizing Fasciitis in Children. Plastic & Reconstructive Surgery 138:3, pages 489e-497e.
Crossref
Crossref
Mark Jit & Raymond Hutubessy. (2016) Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?. Applied Health Economics and Health Policy 14:3, pages 245-252.
Crossref
Crossref
Kei Nagaoka & Takeo Fujiwara. (2016) Impact of Subsidies and Socioeconomic Status on Varicella Vaccination in Greater Tokyo, Japan. Frontiers in Pediatrics 4.
Crossref
Crossref
Oliver Damm, Bernhard Ultsch, Johannes Horn, Rafael T. Mikolajczyk, Wolfgang Greiner & Ole Wichmann. (2015) Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health 15:1.
Crossref
Crossref
Alies van Lier, Anna Lugnér, Wim Opstelten, Petra Jochemsen, Jacco Wallinga, François Schellevis, Elisabeth Sanders, Hester de Melker & Michiel van Boven. (2015) Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster. EBioMedicine 2:10, pages 1494-1499.
Crossref
Crossref
Marta Granström. (2014) The Vaccine Against Varicella. Pediatric Infectious Disease Journal 33:10, pages 1083-1084.
Crossref
Crossref
GS Goldman & PG King. (2013) Vaccination to prevent varicella. Human & Experimental Toxicology 33:8, pages 886-893.
Crossref
Crossref
Kristine Macartney, Anita Heywood & Peter McIntyre. (2014) Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
A. MAHAMUD, J. LEUNG, Y. MASUNU-FALEAFAGA, E. TESHALE, R. WILLIAMS, T. DULSKI, M. THIEME, P. GARCIA, D. S. SCHMID & S. R. BIALEK. (2013) Varicella zoster virus in American Samoa: seroprevalence and predictive value of varicella disease history in elementary and college students. Epidemiology and Infection 142:5, pages 1002-1007.
Crossref
Crossref
Lander Willem, Sean Stijven, Ekaterina Vladislavleva, Jan Broeckhove, Philippe Beutels & Niel Hens. (2014) Active Learning to Understand Infectious Disease Models and Improve Policy Making. PLoS Computational Biology 10:4, pages e1003563.
Crossref
Crossref
Orestis Papaloukas, Georgia Giannouli & Vassiliki Papaevangelou. (2014) Successes and challenges in varicella vaccine. Therapeutic Advances in Vaccines 2:2, pages 39-55.
Crossref
Crossref
Nigel Field, Gayatri Amirthalingam, Pauline Waight, Nick Andrews, Shamez N. Ladhani, Albert Jan van Hoek, Peter A.C. Maple, Kevin E. Brown & Elizabeth Miller. (2014) Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England. Vaccine 32:10, pages 1213-1217.
Crossref
Crossref
Siba P Paul, Hisham Abdelrhim, Meridith Kane & Salma Y Haque. (2013) Varicella and secondary pneumonia in a healthy child: is it time to introduce varicella vaccine in the UK?. British Journal of Hospital Medicine 74:10, pages 590-591.
Crossref
Crossref
G.S. Goldman & P.G. King. (2013) Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data. Vaccine 31:13, pages 1680-1694.
Crossref
Crossref
Paul Kinchington. 2013. Neuroviral Infections. Neuroviral Infections
215
244
.
Bernard A. Cohen. 2013. Pediatric Dermatology. Pediatric Dermatology
104
125
.
Jorien GJ Pierik, Pearl D Gumbs, Sander AC Fortanier, Pauline CE Van Steenwijk & Maarten J Postma. (2012) Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infectious Diseases 12:1.
Crossref
Crossref
Petra Oyston & Karen Robinson. (2012) The current challenges for vaccine development. Journal of Medical Microbiology 61:7, pages 889-894.
Crossref
Crossref
Markus Knuf, Fred Zepp, Klaus Helm, Hartwig Maurer, Albrecht Prieler, Dorothee Kieninger-Baum, Martine Douha & Paul Willems. (2011) Antibody persistence for 3 years following two doses of tetravalent measles–mumps–rubella–varicella vaccine in healthy children. European Journal of Pediatrics 171:3, pages 463-470.
Crossref
Crossref
Albert Jan van Hoek, Alessia Melegaro, Nigel Gay, Joke Bilcke & W. John Edmunds. (2012) The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine 30:6, pages 1225-1234.
Crossref
Crossref
Douglas W. White, R. Suzanne Beard & Erik S. Barton. (2012) Immune modulation during latent herpesvirus infection. Immunological Reviews 245:1, pages 189-208.
Crossref
Crossref
Mark H Rozenbaum, Marie-Josee J Mangen, Carlo Giaquinto, Jan C Wilschut, Eelko Hak & Maarten J Postma. (2011) Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model. BMC Public Health 11:1.
Crossref
Crossref
Judith H Wolleswinkel-van den Bosch, Anouk M Speets, Hans C Rümke, Pearl D Gumbs & Sander C Fortanier. (2011) The burden of varicella from a parent's perspective and its societal impact in The Netherlands: an Internet survey. BMC Infectious Diseases 11:1.
Crossref
Crossref
Mark Jit & Marc Brisson. (2011) Modelling the Epidemiology of Infectious Diseases for Decision Analysis. PharmacoEconomics 29:5, pages 371-386.
Crossref
Crossref
Teresa Jackowska, Alicja Chybicka, Hanna Czajka, Anna Dobrzańska, Ewa Duszczyk, Waleria Hryniewicz, Witold Lukas, Magdalena Marczyńska, Agnieszka Ołdakowska, Paweł Stefanoff, Jacek Wysocki & Leszek Szenborn. (2010) Rekomendacje zespołu ekspertów dotyczące stosowania dwudawkowego schematu szczepień przeciw ospie wietrznej. Pediatria Polska 85:3, pages 243-250.
Crossref
Crossref
J.A. Land, J.E.A.M. Van Bergen, S.A. Morre & M.J. Postma. (2009) Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Human Reproduction Update 16:2, pages 189-204.
Crossref
Crossref
Patricia Cerrito & John CerritoPatricia Cerrito & John Cerrito. 2010. Clinical Data Mining for Physician Decision Making and Investigating Health Outcomes. Clinical Data Mining for Physician Decision Making and Investigating Health Outcomes
287
304
.
Patrícia Coelho de Soárez, Hillegonda Maria Dutilh Novaes & Ana Marli Christovan Sartori. (2009) Impact of methodology on the results of economic evaluations of varicella vaccination programs: is it important for decision-making?. Cadernos de Saúde Pública 25:suppl 3, pages S401-S414.
Crossref
Crossref